Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June-2023 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2023 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Age‑adjusted Charlson comorbidity index and in‑hospital mortality in critically ill patients with cardiogenic shock: A retrospective cohort study

  • Authors:
    • Dongmei Wei
    • Yang Sun
    • Rongtao Chen
    • Yuanting Meng
    • Wei Wu
  • View Affiliations / Copyright

    Affiliations: Department of Cardiovascular Medicine, Liuzhou Traditional Chinese Medical Hospital, Liuzhou, Guangxi Zhuang Autonomous Region 545001, P.R. China, Department of Cardiovascular Medicine, Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region 530000, P.R. China, Department of Cardiovascular Medicine, Guangzhou University of Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong 510405, P.R. China
    Copyright: © Wei et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 299
    |
    Published online on: May 5, 2023
       https://doi.org/10.3892/etm.2023.11998
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Evidence regarding the relationship between age‑adjusted Charlson comorbidity index (ACCI) and in‑hospital mortality is limited. Therefore, the present study investigated whether there was an independent association between ACCI and in‑hospital mortality in critically ill patients with cardiogenic shock (CS) after adjusting for other covariates (age, sex, history of disease, scoring system, in‑hospital management, vital signs at presentation, laboratory findings and vasopressors). ACCI, calculated retrospectively after hospitalization between 2008 and 2019, was derived from intensive care unit (ICU) admissions at the Beth Israel Deaconess Medical Center (Boston, MA, USA). Patients with CS were classified into two categories based on predefined ACCI scores (low, <8; high, ≥8). Based on baseline ACCI, the risk of in‑hospital mortality in patients with CS was calculated using a multivariate Cox proportional risk model, and the threshold effect was calculated using a two‑piece linear regression model. The in‑hospital mortality rate was ~1.5 times greater in the ACCI high group compared with that in the ACCI low group [hazard ratio (HR)=1.45; 95% confidence interval (CI), 1.14‑1.86]. Additional analysis showed that ACCI had a curvilinear association with in‑hospital mortality risk in patients with CS, with a saturation effect predicted at 4.5. When ACCI was >4.5, the risk of in‑hospital CS death increased significantly with increasing ACCI (HR=1.122; 95% CI, 1.054‑1.194). Overall, ACCI was an independent predictor of in‑hospital mortality in ICU patients with CS. A non‑linear relationship was revealed between ACCI and in‑hospital mortality, where in‑hospital mortality increased significantly when ACCI was >4.5.
View Figures
View References

1 

Vahdatpour C, Collins D and Goldberg S: Cardiogenic shock. J Am Heart Assoc. 8(e011991)2019.PubMed/NCBI View Article : Google Scholar

2 

van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, et al: Contemporary management of cardiogenic shock: A scientific statement from the American heart association. Circulation. 136:e232–e268. 2017.PubMed/NCBI View Article : Google Scholar

3 

Goldberg RJ, Makam RCP, Yarzebski J, McManus DD, Lessard D and Gore JM: Decade-long trends (2001-2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 9:117–125. 2016.PubMed/NCBI View Article : Google Scholar

4 

Bahtouee M, Eghbali SS, Maleki N, Rastgou V and Motamed N: Acute physiology and chronic health evaluation II score for the assessment of mortality prediction in the intensive care unit: A single-centre study from Iran. Nurs Crit Care. 24:375–380. 2019.PubMed/NCBI View Article : Google Scholar

5 

Alizadeh AM, Hassanian-Moghaddam H, Shadnia S, Zamani N and Mehrpour O: Simplified acute physiology score II/acute physiology and chronic health evaluation II and prediction of the mortality and later development of complications in poisoned patients admitted to intensive care unit. Basic Clin Pharmacol Toxicol. 115:297–300. 2014.PubMed/NCBI View Article : Google Scholar

6 

Miller RJH, Southern D, Wilton SB, James MT, Har B, Schnell G, van Diepen S and Grant ADM: Comparative prognostic accuracy of risk prediction models for cardiogenic shock. J Intensive Care Med. 35:1513–1519. 2020.PubMed/NCBI View Article : Google Scholar

7 

Harjola VP, Lassus J, Sionis A, Køber L, Tarvasmäki T, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, et al: Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 17:501–509. 2015.PubMed/NCBI View Article : Google Scholar

8 

Pöss J, Köster J, Fuernau G, Eitel I, de Waha S, Ouarrak T, Lassus J, Harjola VP, Zeymer U, Thiele H and Desch S: Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 69:1913–1920. 2017.PubMed/NCBI View Article : Google Scholar

9 

Sleeper LA, Reynolds HR, White HD, Webb JG, Dzavík V and Hochman JS: A severity scoring system for risk assessment of patients with cardiogenic shock: A report from the SHOCK trial and registry. Am Heart J. 160:443–450. 2010.PubMed/NCBI View Article : Google Scholar

10 

Charlson M, Szatrowski TP, Peterson J and Gold J: Validation of a combined comorbidity index. J Clin Epidemiol. 47:1245–1251. 1994.PubMed/NCBI View Article : Google Scholar

11 

Lin JX, Huang YQ, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu R, Huang ZN, et al: Association of the age-adjusted Charlson comorbidity index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy. Eur J Surg Oncol. 45:2465–2472. 2019.PubMed/NCBI View Article : Google Scholar

12 

Jiang L, Chou ACC, Nadkarni N, Ng CEQ, Chong YS, Howe TS and Koh JSB: Charlson comorbidity index predicts 5-year survivorship of surgically treated hip fracture patients. Geriatr Orthop Surg Rehabil. 9(2151459318806442)2018.PubMed/NCBI View Article : Google Scholar

13 

Stavem K, Hoel H, Skjaker SA and Haagensen R: Charlson comorbidity index derived from chart review or administrative data: Agreement and prediction of mortality in intensive care patients. Clin Epidemiol. 9:311–320. 2017.PubMed/NCBI View Article : Google Scholar

14 

Minol JP, Dimitrova V, Petrov G, Langner R, Boeken U, Rellecke P, Aubin H, Kamiya H, Sixt S, Huhn R, et al: The age-adjusted Charlson comorbidity index in minimally invasive mitral valve surgery. Eur J Cardiothorac Surg. 56:1124–1130. 2019.PubMed/NCBI View Article : Google Scholar

15 

Charlson ME, Carrozzino D, Guidi J and Patierno C: Charlson comorbidity index: A critical review of clinimetric properties. Psychother Psychosom. 91:8–35. 2022.PubMed/NCBI View Article : Google Scholar

16 

Johnson Alistair, Bulgarelli Lucas, Pollard Tom, Horng Steven, Celi Leo Anthony and Roger Mark: MIMIC-IV (version 2.0). Available from: https://doi.org/10.13026/7vcr-e114.

17 

World Health Organization (WHO). International classification of diseases: [9th] ninth revision, basic tabulation list with alphabetic index. WHO, Geneva, 1978. https://apps.who.int/iris/handle/10665/39473.

18 

World Health Organization (WHO). International statistical classification of diseases and related health problems. 10th revision. 5th edition. WHO, Geneva, 2016. https://apps.who.int/iris/handle/10665/246208.

19 

Chang CM, Yin WY, Wei CK, Wu CC, Su YC, Yu CH and Lee CC: Adjusted age-adjusted charlson comorbidity index score as a risk measure of perioperative mortality before cancer surgery. PLoS One. 11(e0148076)2016.PubMed/NCBI View Article : Google Scholar

20 

Saji M, Katz MR, Ailawadi G, Fowler DE, Ragosta M and Lim DS: Predictive value of age-adjusted charlson co-morbidity index for 1-, 3-, and 5-year mortality in patients requiring transcatheter mitral valve repair. Am J Cardiol. 120:309–314. 2017.PubMed/NCBI View Article : Google Scholar

21 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC and Vandenbroucke JP: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 370:1453–1457. 2007.PubMed/NCBI View Article : Google Scholar

22 

Yu X, Chen J, Li Y, Liu H, Hou C, Zeng Q, Cui Y, Zhao L, Li P, Zhou Z, et al: Threshold effects of moderately excessive fluoride exposure on children's health: A potential association between dental fluorosis and loss of excellent intelligence. Environ Int. 118:116–124. 2018.PubMed/NCBI View Article : Google Scholar

23 

Kong X, Huang X, Zhao M, Xu B, Xu R, Song Y, Yu Y, Yang W, Zhang J, Liu L, et al: Platelet count affects efficacy of folic acid in preventing first stroke. J Am Coll Cardiol. 71:2136–2146. 2018.PubMed/NCBI View Article : Google Scholar

24 

Park SY, Freedman ND, Haiman CA, Le Marchand L, Wilkens LR and Setiawan VW: Association of coffee consumption with total and cause-specific mortality among nonwhite populations. Ann Intern Med. 167:228–235. 2017.PubMed/NCBI View Article : Google Scholar

25 

Barssoum K, Patel HP, Abdelmaseih R, Hassib M, Victor V, Mohamed A, Jazar DA, Mai S, Ibrahim F, Patel B, et al: Characteristics and outcomes of early vs late initiation of mechanical circulatory support in non-acute myocardial infarction related cardiogenic shock: An analysis of the national inpatient sample database. Curr Probl Cardiol. 48(101584)2023.PubMed/NCBI View Article : Google Scholar

26 

Assali AR, Iakobishvili Z, Zafrir N, Solodky A, Teplitsky I, Rechavia E, Butto N, Shor N, Hasdai D, Fuchs S, et al: Characteristics and clinical outcomes of patients with cardiogenic shock complicating acute myocardial infarction treated by emergent coronary angioplasty. Int J Cardiovasc Intervent. 7:193–198. 2005.PubMed/NCBI View Article : Google Scholar

27 

Lee SI, Koh Y, Huh JW, Hong SB and Lim CM: Factors and outcomes of intensive care unit readmission in elderly patients. Gerontology. 68:280–288. 2022.PubMed/NCBI View Article : Google Scholar

28 

Wang Y, Yuan M, Ma Y, Shao C, Wang Y, Qi M, Ren B and Gao D: The admission (Neutrophil+Monocyte)/lymphocyte ratio is an independent predictor for in-hospital mortality in patients with acute myocardial infarction. Front Cardiovasc Med. 9(870176)2022.PubMed/NCBI View Article : Google Scholar

29 

Feng M, McSparron JI, Kien DT, Stone DJ, Roberts DH, Schwartzstein RM, Vieillard-Baron A and Celi LA: Transthoracic echocardiography and mortality in sepsis: Analysis of the MIMIC-III database. Intensive Care Med. 44:884–892. 2018.PubMed/NCBI View Article : Google Scholar

30 

Chen H, Zhu Z, Zhao C, Guo Y, Chen D, Wei Y and Jin J: Central venous pressure measurement is associated with improved outcomes in septic patients: An analysis of the MIMIC-III database. Crit Care. 24(433)2020.PubMed/NCBI View Article : Google Scholar

31 

Feinstein AR: The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 23:455–468. 1970.PubMed/NCBI View Article : Google Scholar

32 

Charlson ME, Pompei P, Ales KL and MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 40:373–383. 1987.PubMed/NCBI View Article : Google Scholar

33 

Wu CC, Hsu TW, Chang CM, Yu CH and Lee CC: Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation. Medicine (Baltimore). 94(e431)2015.PubMed/NCBI View Article : Google Scholar

34 

Yang CC, Fong Y, Lin LC, Que J, Ting WC, Chang CL, Wu HM, Ho CH, Wang JJ and Huang CI: The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices. Eur J Cardiothorac Surg. 53:235–240. 2018.PubMed/NCBI View Article : Google Scholar

35 

Hoang TH, Maiskov VV, Merai IA and Kobalava ZD: Development and validation of a model for predicting 18-month mortality in type 2 myocardial infarction. Am J Emerg Med. 48:224–230. 2021.PubMed/NCBI View Article : Google Scholar

36 

Shebeshi DS, Dolja-Gore X and Byles J: Charlson Comorbidity index as a predictor of repeated hospital admission and mortality among older women diagnosed with cardiovascular disease. Aging Clin Exp Res. 33:2873–2878. 2021.PubMed/NCBI View Article : Google Scholar

37 

Hsu YT, He YT, Ting CK, Tsou MY, Tang GJ and Pu C: Administrative and claims data help predict patient mortality in intensive care units by logistic regression: A nationwide database study. Biomed Res Int. 2020(9076739)2020.PubMed/NCBI View Article : Google Scholar

38 

Hadique S, Culp S, Sangani RG, Chapman KD, Khan S, Parker JE and Moss AH: Derivation and validation of a prognostic model to predict 6-month mortality in an intensive care unit population. Ann Am Thorac Soc. 14:1556–1561. 2017.PubMed/NCBI View Article : Google Scholar

39 

Radovanovic D, Seifert B, Urban P, Eberli FR, Rickli H, Bertel O, Puhan MA and Erne P: Validity of Charlson Comorbidity index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart. 100:288–294. 2014.PubMed/NCBI View Article : Google Scholar

40 

Jepma P, Verweij L, Tijssen A, Heymans MW, Flierman I, Latour CHM, Peters RJG, Reimer WJM, Buurman BM and Riet GT: The performance of the dutch safety management system frailty tool to predict the risk of readmission or mortality in older hospitalised cardiac patients. BMC Geriatr. 21(299)2021.PubMed/NCBI View Article : Google Scholar

41 

George S, Kwok CS, Martin GP, Babu A, Shufflebotham A, Nolan J, Ratib K, Bagur R, Gunning M and Mamas M: The influence of the Charlson Comorbidity index on procedural characteristics, VARC-2 endpoints and 30-day mortality among patients who undergo transcatheter aortic valve implantation. Heart Lung Circ. 28:1827–1834. 2019.PubMed/NCBI View Article : Google Scholar

42 

Abraham J, Blumer V, Burkhoff D, Pahuja M, Sinha SS, Rosner C, Vorovich E, Grafton G, Bagnola A, Hernandez-Montfort JA and Kapur NK: Heart failure-related cardiogenic shock: Pathophysiology, evaluation and management considerations: Review of heart failure-related cardiogenic shock. J Card Fail. 27:1126–1140. 2021.PubMed/NCBI View Article : Google Scholar

43 

Dalzell JR: Review of cardiogenic shock after acute myocardial infarction. JAMA. 327(878)2022.PubMed/NCBI View Article : Google Scholar

44 

Bertini P and Guarracino F: Pathophysiology of cardiogenic shock. Curr Opin Crit Care. 27:409–415. 2021.PubMed/NCBI View Article : Google Scholar

45 

Lassus J, Tarvasmäki T and Tolppanen H: Biomarkers in cardiogenic shock. Adv Clin Chem. 109:31–73. 2022.PubMed/NCBI View Article : Google Scholar

46 

Krychtiuk KA, Vrints C, Wojta J, Huber K and Speidl WS: Basic mechanisms in cardiogenic shock: Part 1-definition and pathophysiology. Eur Heart J Acute Cardiovasc Care. 11:356–365. 2022.PubMed/NCBI View Article : Google Scholar

47 

Wireklint SC, Elmqvist C, Fridlund B and Göransson KE: A longitudinal, retrospective registry-based validation study of RETTS©, the Swedish adult ED context version. Scand J Trauma Resusc Emerg Med. 30(27)2022.PubMed/NCBI View Article : Google Scholar

48 

Lu KJ, Kearney LG, Ord M, Jones E, Burrell LM and Srivastava PM: Age adjusted Charlson Co-morbidity index is an independent predictor of mortality over long-term follow-up in infective endocarditis. Int J Cardiol. 168:5243–5248. 2013.PubMed/NCBI View Article : Google Scholar

49 

Zhang N, Lin Q, Jiang H and Zhu H: Age-adjusted Charlson Comorbidity index as effective predictor for in-hospital mortality of patients with cardiac arrest: A retrospective study. BMC Emerg Med. 23(7)2023.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wei D, Sun Y, Chen R, Meng Y and Wu W: Age‑adjusted Charlson comorbidity index and in‑hospital mortality in critically ill patients with cardiogenic shock: A retrospective cohort study. Exp Ther Med 25: 299, 2023.
APA
Wei, D., Sun, Y., Chen, R., Meng, Y., & Wu, W. (2023). Age‑adjusted Charlson comorbidity index and in‑hospital mortality in critically ill patients with cardiogenic shock: A retrospective cohort study. Experimental and Therapeutic Medicine, 25, 299. https://doi.org/10.3892/etm.2023.11998
MLA
Wei, D., Sun, Y., Chen, R., Meng, Y., Wu, W."Age‑adjusted Charlson comorbidity index and in‑hospital mortality in critically ill patients with cardiogenic shock: A retrospective cohort study". Experimental and Therapeutic Medicine 25.6 (2023): 299.
Chicago
Wei, D., Sun, Y., Chen, R., Meng, Y., Wu, W."Age‑adjusted Charlson comorbidity index and in‑hospital mortality in critically ill patients with cardiogenic shock: A retrospective cohort study". Experimental and Therapeutic Medicine 25, no. 6 (2023): 299. https://doi.org/10.3892/etm.2023.11998
Copy and paste a formatted citation
x
Spandidos Publications style
Wei D, Sun Y, Chen R, Meng Y and Wu W: Age‑adjusted Charlson comorbidity index and in‑hospital mortality in critically ill patients with cardiogenic shock: A retrospective cohort study. Exp Ther Med 25: 299, 2023.
APA
Wei, D., Sun, Y., Chen, R., Meng, Y., & Wu, W. (2023). Age‑adjusted Charlson comorbidity index and in‑hospital mortality in critically ill patients with cardiogenic shock: A retrospective cohort study. Experimental and Therapeutic Medicine, 25, 299. https://doi.org/10.3892/etm.2023.11998
MLA
Wei, D., Sun, Y., Chen, R., Meng, Y., Wu, W."Age‑adjusted Charlson comorbidity index and in‑hospital mortality in critically ill patients with cardiogenic shock: A retrospective cohort study". Experimental and Therapeutic Medicine 25.6 (2023): 299.
Chicago
Wei, D., Sun, Y., Chen, R., Meng, Y., Wu, W."Age‑adjusted Charlson comorbidity index and in‑hospital mortality in critically ill patients with cardiogenic shock: A retrospective cohort study". Experimental and Therapeutic Medicine 25, no. 6 (2023): 299. https://doi.org/10.3892/etm.2023.11998
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team